These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 25125625

  • 1. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
    Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G.
    Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
    [Abstract] [Full Text] [Related]

  • 2. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC.
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [Abstract] [Full Text] [Related]

  • 3. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
    Hsi AC, Robirds DH, Luo J, Kreisel FH, Frater JL, Nguyen TT.
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [Abstract] [Full Text] [Related]

  • 4. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ.
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [Abstract] [Full Text] [Related]

  • 5. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
    Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K, Gervais C, Nguyen-Khac F, Chapiro E, Radford-Weiss I, Struski S, Dastugue N, Gachard N, Lefebvre C, Barin C, Eclache V, Fert-Ferrer S, Laibe S, Mozziconacci MJ, Quilichini B, Poirel HA, Wlodarska I, Hagemeijer A, Moreau Y, Vandenberghe P, Michaux L, BCGHo and the GFCH.
    Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
    [Abstract] [Full Text] [Related]

  • 6. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
    Chapiro E, Pramil E, Diop M, Roos-Weil D, Dillard C, Gabillaud C, Maloum K, Settegrana C, Baseggio L, Lesesve JF, Yon M, Jondreville L, Lesty C, Davi F, Le Garff-Tavernier M, Droin N, Dessen P, Algrin C, Leblond V, Gabarre J, Bouzy S, Eclache V, Gaillard B, Callet-Bauchu E, Muller M, Lefebvre C, Nadal N, Ittel A, Struski S, Collonge-Rame MA, Quilichini B, Fert-Ferrer S, Auger N, Radford-Weiss I, Wagner L, Scheinost S, Zenz T, Susin SA, Bernard OA, Nguyen-Khac F, the Groupe Francophone de Cytogénétique Hématologique (GFCH), the French Innovative Leukemia Organization (FILO).
    Blood; 2019 Nov 21; 134(21):1821-1831. PubMed ID: 31527074
    [Abstract] [Full Text] [Related]

  • 7. B-cell prolymphocytic leukemia carrying t(8;14)(q24;q32), associated with both autoimmune hemolytic anemia and pure red cell aplasia.
    Iioka F, Akasaka T, Hayashida M, Okumura A, Ohno H.
    J Clin Exp Hematop; 2014 Nov 21; 54(3):219-24. PubMed ID: 25501113
    [Abstract] [Full Text] [Related]

  • 8. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Cavazzini F, Milani R, Minotto C, Tieghi A, Della Porta M, Agostini P, Tammiso E, Negrini M, Castoldi G.
    Haematologica; 2002 Jan 21; 87(1):44-51. PubMed ID: 11801464
    [Abstract] [Full Text] [Related]

  • 9. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
    Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ.
    Arch Pathol Lab Med; 2003 Mar 21; 127(3):305-9. PubMed ID: 12653573
    [Abstract] [Full Text] [Related]

  • 10. Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations.
    Damlaj M, Al Balwi M, Al Mugairi AM.
    Leuk Lymphoma; 2018 Mar 21; 59(3):739-742. PubMed ID: 28695755
    [No Abstract] [Full Text] [Related]

  • 11. Expression of c-myc oncoprotein in chronic T cell leukemias.
    Maljaie SH, Brito-Babapulle V, Matutes E, Hiorns LR, De Schouwer PJ, Catovsky D.
    Leukemia; 1995 Oct 21; 9(10):1694-9. PubMed ID: 7564512
    [Abstract] [Full Text] [Related]

  • 12. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP, Variakojis D, Peterson LC.
    Mod Pathol; 2002 Nov 21; 15(11):1111-20. PubMed ID: 12429788
    [Abstract] [Full Text] [Related]

  • 13. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A, Wanquet A, Maitre E, Cornet E, Troussard X, Aurran-Schleinitz T.
    Curr Oncol Rep; 2017 Apr 21; 19(4):29. PubMed ID: 28324286
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
    Brito-Babapulle V, Pittman S, Melo JV, Pomfret M, Catovsky D.
    Hematol Pathol; 1987 Apr 21; 1(1):27-33. PubMed ID: 3509770
    [Abstract] [Full Text] [Related]

  • 15. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
    Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ.
    Am J Clin Pathol; 2001 Apr 21; 115(4):571-81. PubMed ID: 11293906
    [Abstract] [Full Text] [Related]

  • 16. B-prolymphocytic leukemia: Is it time to retire this entity?
    El Hussein S, Khoury JD, Medeiros LJ.
    Ann Diagn Pathol; 2021 Oct 21; 54():151790. PubMed ID: 34293709
    [Abstract] [Full Text] [Related]

  • 17. Richter transformation with c-MYC overexpression: report of three cases.
    Wang L, Aghel A, Peterson B, Wang-Rodriguez J, Wang HY, Zhao XF.
    Int J Clin Exp Pathol; 2015 Oct 21; 8(6):7540-6. PubMed ID: 26261666
    [Abstract] [Full Text] [Related]

  • 18. An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia.
    Bell S, Lattanzio N, Braham J, Campdesuner V, Abdelal Q, Vartanov A, Pelayo M.
    J Investig Med High Impact Case Rep; 2021 Oct 21; 9():2324709621990767. PubMed ID: 33533282
    [Abstract] [Full Text] [Related]

  • 19. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
    Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D.
    Br J Haematol; 2004 May 21; 125(3):330-6. PubMed ID: 15086413
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X.
    Am J Hematol; 2017 May 21; 92(5):441-447. PubMed ID: 28194886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.